Wei‐Ming Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Urology top 2%
- Urinary Bladder and Prostate Research
Papers in
- Surgery 96
- Bladder and Urothelial Cancer Treatments 79
- Coronary Interventions and Diagnostics 8
- Hematology 21
- Chronic Myeloid Leukemia Treatments 12
- Co-authors
- Wen‐Jeng Wu (101 shared papers)Ching‐Chia Li (66 shared papers)Hung‐Lung Ke (63 shared papers)Chun‐Nung Huang (42 shared papers)Hsin‐Chih Yeh (49 shared papers)Chien-Feng L Li (35 shared papers)Yii‐Her Chou (25 shared papers)Yawei Xu (13 shared papers)
- Journals
- Frontiers in Oncology (9 papers)Scientific Reports (6 papers)Oncotarget (6 papers)Urologic Oncology Seminars and Original Investigations (5 papers)The Journal of Sexual Medicine (5 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wei‐Ming Li
268 papers receiving 5.3k citations
Wei‐Ming Li's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 420
- Urology 172
- Surgery 927
- Oncology 441
- Biomaterials 216
Countries citing papers authored by Wei‐Ming Li
This map shows the geographic impact of Wei‐Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Li more than expected).
Fields of papers citing papers by Wei‐Ming Li
This network shows the impact of papers produced by Wei‐Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Li. The network helps show where Wei‐Ming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 281 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In Vivo Hit paper breakdown → | 2011 | 505 |
| 2 | 2010 | 138 | |
| 3 | 2016 | 128 | |
| 4 | Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. | 2007 | 113 |
| 5 | 2005 | 97 | |
| 6 | 2014 | 93 | |
| 7 | 2008 | 90 | |
| 8 | 2018 | 85 | |
| 9 | 2022 | 82 | |
| 10 | 2020 | 80 | |
| 11 | 2012 | 76 | |
| 12 | 2009 | 70 | |
| 13 | 2020 | 69 | |
| 14 | 2007 | 62 | |
| 15 | 2015 | 60 | |
| 16 | 2011 | 58 | |
| 17 | 2012 | 57 | |
| 18 | 2003 | 56 | |
| 19 | 2018 | 56 | |
| 20 | 2011 | 55 |
About Wei‐Ming Li
Wei‐Ming Li is a scholar working on Surgery, Hematology, Cancer Research, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 281 papers that have together received 5.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (79 papers), MicroRNA in disease regulation (13 papers), Chronic Myeloid Leukemia Treatments (12 papers), Kidney Stones and Urolithiasis Treatments (11 papers), Acute Myocardial Infarction Research (10 papers), Coronary Interventions and Diagnostics (8 papers), Sexual function and dysfunction studies (7 papers) and Urinary Bladder and Prostate Research (7 papers). The work is most often cited by research in Cancer Research (420 citations), Urology (172 citations), Surgery (927 citations), Oncology (441 citations) and Biomaterials (216 citations). Wei‐Ming Li has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Jeng Wu, Ching‐Chia Li, Hung‐Lung Ke, Chun‐Nung Huang, Hsin‐Chih Yeh, Chien-Feng L Li, Yii‐Her Chou, Yawei Xu, San-Yuan Chen and Chia‐Chu Liu. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Oncotarget, Urologic Oncology Seminars and Original Investigations and The Journal of Sexual Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.